Mayo: Supreme Court case is about how far patents can go
Mayo Clinic is not asking the US Supreme Court for an “exotic” application of Section 101, and the personalised medicine industry will be fine without patents like that owned by Prometheus, the company’s counsel told Managing IP on Thursday
“Mayo is relying on very traditional Supreme Court precedents that have been around for 50 or 100 years,” said Mayo’s outside counsel Jonathan Singer of Fish & Richardson.
“Mayo’s not pushing some new view of the law under 101. This...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.